Zobrazeno 1 - 10
of 153
pro vyhledávání: '"vasoactive hormones"'
Autor:
Naranjan S. Dhalla, Karina O. Mota, Vijayan Elimban, Anureet K. Shah, Carla M. L. de Vasconcelos, Sukhwinder K. Bhullar
Publikováno v:
Cells, Vol 13, Iss 10, p 856 (2024)
Heart failure is the common concluding pathway for a majority of cardiovascular diseases and is associated with cardiac dysfunction. Since heart failure is invariably preceded by adaptive or maladaptive cardiac hypertrophy, several biochemical mechan
Externí odkaz:
https://doaj.org/article/648f1e39bddf4a5d92082c035078c28c
Autor:
Keiser, Joan A., Ryan, Michael J.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1996 May . 93(10), 4957-4961.
Externí odkaz:
https://www.jstor.org/stable/38884
Publikováno v:
Antioxidants, Vol 10, Iss 6, p 931 (2021)
Although heart failure due to a wide variety of pathological stimuli including myocardial infarction, pressure overload and volume overload is associated with cardiac hypertrophy, the exact reasons for the transition of cardiac hypertrophy to heart f
Externí odkaz:
https://doaj.org/article/870dff2be12945a0b36f798a4f4a1cf8
Publikováno v:
Терапевтический архив, Vol 78, Iss 6, Pp 79-84 (2003)
Externí odkaz:
https://doaj.org/article/a59e447b9916473eb013494ba658d518
Publikováno v:
Antioxidants
Antioxidants, Vol 10, Iss 931, p 931 (2021)
Antioxidants, Vol 10, Iss 931, p 931 (2021)
Although heart failure due to a wide variety of pathological stimuli including myocardial infarction, pressure overload and volume overload is associated with cardiac hypertrophy, the exact reasons for the transition of cardiac hypertrophy to heart f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9074bc7e128af5024fa0af184c6f4446
http://europepmc.org/articles/PMC8228897
http://europepmc.org/articles/PMC8228897
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Botasheva T.L. Botasheva, Zheleznyakova E.V. Zheleznyakova, Avrutskaya V.V. Avrutskaya, Linde V.A. Linde, Palieva N.V. Palieva
Publikováno v:
Akusherstvo i ginekologiia. :48-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9766e32bbb615553ebfeda6a907a60e2
https://doi.org/10.18565/aig.2017.6.48-54
https://doi.org/10.18565/aig.2017.6.48-54
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erling B. Pedersen, Joergen Kühlwein Johansen, Niels Peter Ekeloef, Anne Sophie Pinholt Kancir
Publikováno v:
Kancir, A S P, Johansen, J K, Ekeloef, N P & Pedersen, E B 2015, ' The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy : a randomized controlled trial ', Anesthesia and Analgesia, vol. 120, no. 3, pp. 608-18 . https://doi.org/10.1213/ANE.0000000000000596
BACKGROUND: Although hydroxyethyl starch (HES) is commonly used as an intravascular volume expander in surgical patients, recent studies suggest that it may increase the risk of renal failure in critically ill patients. We hypothesized that patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b19f2c76f3ef4d0efd0eb4c55d0acc36
https://doi.org/10.1213/ane.0000000000000596
https://doi.org/10.1213/ane.0000000000000596
Autor:
Jeppe Bakkestroem Rosenbaek, Jesper Noergaard Bech, Safa Al Therwani, Erling B. Pedersen, My Emma Sofie Malmberg
Publikováno v:
Therwani, S, Malmberg, M E S, Rosenbaek, J B, Bech, J N & Pedersen, E B 2017, ' Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system : a randomized, placebo-controlled, double blind, crossover study ', B M C Nephrology, vol. 18, no. 1, 268 . https://doi.org/10.1186/s12882-017-0686-3
BMC Nephrology
BMC Nephrology, Vol 18, Iss 1, Pp 1-13 (2017)
BMC Nephrology
BMC Nephrology, Vol 18, Iss 1, Pp 1-13 (2017)
Background: Tolvaptan slows progression of autosomal dominant polycystic kidney disease (ADPKD) by antagonizing the vasopressin-cAMP axis. Nitric oxide (NO) stimulates natriuresis and diuresis, but its role is unknown during tolvaptan treatment in AD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2993eaa515356b9d291f1369a682f42
https://pure.au.dk/portal/da/publications/effect-of-tolvaptan-on-renal-handling-of-water-and-sodium-gfr-and-central-hemodynamics-in-autosomal-dominant-polycystic-kidney-disease-during-inhibition-of-the-nitric-oxide-system(853a65b1-8199-401d-b742-88b97a519b1f).html
https://pure.au.dk/portal/da/publications/effect-of-tolvaptan-on-renal-handling-of-water-and-sodium-gfr-and-central-hemodynamics-in-autosomal-dominant-polycystic-kidney-disease-during-inhibition-of-the-nitric-oxide-system(853a65b1-8199-401d-b742-88b97a519b1f).html
